跳至主要内容
临床试验/ACTRN12619000062123
ACTRN12619000062123已完成未知

Sub-epithelial Connective Tissue Graft with or without enamel matrix derivative for the treatment of multiple Class III-IV recessions in lower anterior teeth, assessment of collagen-stabilized anorganic bovine bone mineral with 10% collagen with or without enamel matrix derivative in ridge management and management of peri-implantitis.

Dr. Faustino Mercado0 个研究点目标入组 42 人开始时间: 2019年1月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
42

研究概览

简要总结

The addition of emdogain with gum graft resulted in better root coverage of gum recession and thicker gum in the lower anterior teeth when compared to gum graft alone. It also resulted in significantly less pain in the first 2 weeks after the surgery. The addition of emdogain with bone graft managed to control the peri-implantitis progression within the first 2 years after deep cleaning.

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • Systemically healthy stable/treated periodontal condition, non-smokers and aged between 18-70 years old, not pregnant or lactating, not taking any steroid medications, bisphosponates or anti-depressive medications.
  • Eligible participants will be allocated to one of the four above-mentioned treatment groups after an initial examination by a trained dental surgeon. A unique identifier number will be assigned to each participant at this time to provide confidentiality throughout the study.

排除标准

  • Smokers, Patients with uncontrolled diabetes, those taking bisphosphonates, anti-depressants and antipsychotic medications, and pregnant or lactating females were excluded from the study

研究者

发起方
Dr. Faustino Mercado

相似试验